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Background: Sexual dimorphism in brain size is common among primates, including humans, apes and some Old
World monkeys. In these species, the brain size of males is generally larger than that of females. Curiously, this
dimorphism has persisted over the course of primate evolution and human origin, but there is no explanation for
the underlying genetic controls that have maintained this disparity in brain size.
Results: In the present study, we tested the effect of the female hormone (estradiol) on seven genes known to be
related to brain size in both humans and nonhuman primates, and we identified half estrogen responsive elements
(half EREs) in the promoter regions of four genes (MCPH1, ASPM, CDK5RAP2 and WDR62). Likewise, at sequence level, it
appears that these half EREs are generally conserved across primates. Later testing via a reporter gene assay and cell-based
endogenous expression measurement revealed that estradiol could significantly suppress the expression of the four
affected genes involved in brain size. More intriguingly, when the half EREs were deleted from the promoters, the
suppression effect disappeared, suggesting that the half EREs mediate the regulation of estradiol on the brain size
genes. We next replicated these experiments using promoter sequences from chimpanzees and rhesus macaques,
and observed a similar suppressive effect of estradiol on gene expression, suggesting that this mechanism is conserved
among primate species that exhibit brain size dimorphism.
Conclusions: Brain size dimorphism among certain primates, including humans, is likely regulated by estrogen through
its sex-dependent suppression of brain size genes during development.
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Sexual dimorphism is a common phenomenon in humans
and many non-human primate species, such as chimpan-
zees and rhesus macaques. It is exhibited in a variety of
physical characteristics, such as body size, brain size, hair
color and skeletal structure, as well as the central nervous
system (CNS) [1]. For CNS, the most obvious sexual di-
morphism is the size of the brain. Among numerous pri-
mates, males have larger brains than females; in humans
for example, on average the total brain volume of males is* Correspondence: sub@mail.kiz.ac.cn
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creativecommons.org/publicdomain/zero/1.0/about 11 % larger than in females. Similar differences also
exist for regional brain volumes: total grey matter volume
(9 % larger), and cerebellum volume (9 % larger) [2–4].
Brain size dimorphism is curiously prominent in apes and
humans as well as in some Old World monkey species
such as macaques, but no brain size dimorphism is
present in New World monkeys (such as common mar-
moset) or prosimians (such as lorises) [5]. This disparity
suggests that the origin of brain size dimorphism in pri-
mates is a relatively recent event, one that occurred after
the split between Old and New World monkeys about 45
million years ago. Brain size dimorphism also exists in
many non-primate mammalian species [6], suggesting
multiple origins of this phenomenon during evolution.
One of the hallmarks of primate evolution, and par-
ticularly the origin of humans, is an ever-increasing
brain size. To date, most studies on brain evolution havee distributed under the terms of the Creative Commons Attribution License
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between-species divergence of brain size among pri-
mates, especially between humans and non-human pri-
mates [7]. These studies have found a series of genes
regulating brain size. In humans, truncated mutations of
these genes would cause a rare human genetic disorder,
primary microcephaly (MCPH, OMIM#251200), which is
characterized by a severe reduction of brain size as well as
mild to severe cognitive impairment [8]. The genes pur-
portedly related to MCPH include BRIT1/MCPH1
(BRCT-repeat inhibitor of hTERT expression [9, 10],
which encodes microcephalin; locus MCPH1), WDR62
(WD repeat domain 62; MCPH2) [11–13], CDK5RAP2
(cyclin-dependent kinase 5 regulatory associated protein 2;
MCPH3) [14], CEP152(centrosomal protein 152 kDa;
MCPH4) [15], ASPM(abnormal spindle-like microcephaly-
associated protein; MCPH5) [16], CENPJ(centromeric pro-
tein J; MCPH6) [14], and STIL(SCL/TAL1 interrupting
locus; MCPH7) [17]. Interestingly, all seven MCPH genes
encode centrosome or spindle pole proteins taking part in
proper centrosome or mitotic microtubule organization
[18], indicating their important roles during neurogenesis.
Likewise, gene knockout mouse models of three MCPH
genes (ASPM, CDK5RAP2 and MCPH1) all resulted in
marked reduction in brain size [19–22].
Of the seven identified MCPH genes, four were previ-
ously shown to have undergone rapid evolution at the
protein sequence level due to Darwinian positive selection
during primate evolution, suggesting that these genes con-
tributed to the evolution of the primate brains, and by ex-
tension human brains [23, 24]. Among humans, previous
studies showed that sequence variations in three of these
MCPH genes (ASPM, CDK5RAP2 and MCPH1) are asso-
ciated with brain size and structure, but in a sex
dependent manner [25, 26], implying that MCPH genes
may be in some way regulated by sex hormones. If accur-
ate, it stands to reason that the sex-dependent differences
in the expression of these genes may contribute to the sex-
ual dimorphism in the brain sizes observed among humans
and certain nonhuman primates. Although no reliable data
is available to indicate the assumed difference of sex hor-
mone levels in the brain between males and females, it was
reported in humans that puberty time (when sex hormones
take into effect) plays an important role in shaping up the
difference in brain development between males and fe-
males [27–29]. Unfortunately, the underlying mechanisms
that would explain this effect are still unknown.
Estrogen is known to be a key regulator of development
of female reproductive system and secondary sexual charac-
teristics, but it also plays a role in neural functions by en-
gaging in signaling on synaptic proteins, connectivity and
synaptic function [30]. It has three forms, including estra-
diol, estriol and estrone, among which estradiol is the pre-
dominant estrogen during reproductive years both in termsof absolute serum levels as well as in terms of estrogenic ac-
tivity. The estrogen receptor (ER) is a member of the ster-
oid/nuclear receptor super-family of transcription factors
that is required for mediating estrogen-induced responses
[31]. While a large number of genes can be regulated by es-
trogen [32], it has never been tested whether MCPH genes
are direct targets of estrogen. In this study, we investigated
the regulation of estradiol on the seven MCPH genes, and
found that four of them (ASPM, CDK5RAP2, MCPH1 and
WDR62) can be regulated by estradiol. We then examined
the effects of estradiol on the promoter activity of these four
MCPH genes and found that estradiol is capable of sup-
pressing the promoter activities of these MCPH genes in
both humans and nonhuman primates, and moreover that
this suppression mechanism may contribute to the differen-
tial development and sexual dimorphic size differences ob-
served between the male and female primate brains.
Results
Identification of estrogen responsive elements in four
microcephaly genes
To determine whether estradiol could regulate the seven
currently known microcephaly genes (ASPM, CENPJ,
CEP152, CDK5RAP2, MCPH1, STIL and WDR62), we
conducted a search of the potential ERE (estrogen re-
sponse element) sites in gene promoter regions. Four
genes (ASPM, CDK5RAP2, MCPH1 and WDR62) con-
tain predicted half ERE sites (TGACC or GGTCA) in
their promoters (Fig. 1) [33, 34]. In total, there are two
predicted half ERE sites in ASPM (Fig. 1), six in
CDK5RAP2 (Fig. 1), three in MCPH1 (Fig. 1) and two in
WDR62 (Fig. 1). Sequence alignments of the promoter
regions of representative primate species and mouse
indicated that the predicted half ERE sites are, in general,
conserved among human and nonhuman primates (Fig. 1),
implying functional constraints on these half ERE sites.
However, for ASPM and MCPH1, 4 out of the 5 half ERE
sites are not conserved in marmosets (Fig. 1).
To test whether the predicted half ERE sites are func-
tional, we cloned the promoters of the four genes
(Additional file 1: Figure S1; human promoters were
used) into luciferase vectors and then assayed their cap-
acity of modulating promoter activity in response to estra-
diol treatment of the transfected HEK293T cells. The 17-
β-estradiol (abbreviated as E2) was used. We found that
E2 (20 nm) could regulate the promoter activities of all
four microcephaly genes, significantly repressing the pro-
moter activities with the presence of ERα (Fig. 2). On aver-
age, the down-regulation levels of the four MCPH genes
were 39 % for MCPH1, 43 % for WDR62, 19 % for ASPM
and 23 % for CDK5RAP2. We further tested different E2
dosages (1nM-50nM), and the results remained the same
(Additional file 1: Figure S1 and Additional file 2: Figure S2).
Fig. 1 Identification of half EREs in the MCPH gene promoter sequences. The half EREs were mapped based on the gene’s translational start site
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In order to clarify whether E2’s regulation on the MCPH
genes is mediated by direct interaction between E2 and the
predicted half ERE sites, we designed a mutant assay by de-
leting the half ERE sites in the promoters. For ASPM, wheneither of the two half ERE sites was deleted, the repressive
effect disappeared (Fig. 2a), indicating that the two half
ERE sites are necessary for ASPM’s response to E2’s regula-
tion. Similarly, for CDK5RAP2, among the six half ERE
sites, three showed loss of the repressive effects but the
Fig. 2 E2 represses the promoter activities of four MCPH genes. a Quantification of repressive activity of ASPM gene and the ASPM-1326 and
ASPM-86 deletion mutants using luciferase reporter gene assay. b Quantification of repressive activity with deletion mutations of half ERE
sequence at −1060, −726, −654,-525,-504 and −201 upstream of the CDK5RAP2 translation start site and CDK5RAP2 gene using luciferase
reporter gene assay. c Quantification of repressive activity with deletion mutations of half ERE sequence at −1404, −754 and −632 upstream of the
MCPH1 translation start site and also MCPH1 gene, using luciferase reporter gene assay. d Quantification of repressive activity with deletion mutations
of half ERE sequence at −727 and −1679 upstream of the WDR62 translation start site and WDR62 gene using luciferase reporter gene assay. The HEK293T
cells were transiently transfected with vector containing human ERα
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half ERE sites showed a loss of repression when deleted
(Fig. 2c), while one of the two half ERE sites for WDR62
appeared to be necessary for E2’s regulation (Fig. 2d).
Taken collectively, the mutant assay demonstrated that the
regulation of E2 on the four MCPH genes is mediated by
interaction with the half ERE sites. Interestingly, we did
not observe a graded phenotype of the loss of repression in
the mutant assays, an implication of a possible cooperative
effect among the half ERE sites.
E2 represses endogenous MCPH gene expression
Given the observed repression of the promoter activities of
the four MCPH genes in the reporter gene assays, we tested
the effects of E2 on endogenous gene expression. The
HEK293Tcells capable of expressing estrogen receptors [35]
were used to quantify mRNA expression of the four MCPH
genes under E2 treatments (DMSO was used as controlbecause E2 is dissolved in DMSO). The results showed that
all four MCPH genes were down-regulated endogenously
in the HEK293T cells following E2 treatments of 24 h
(p < 0.05, t test) (Fig. 3a). The same effect was also seen in
the E2 treated MCF7 cells and K562 cells (p < 0.01, t test)
(Fig. 3b and c). Additionally, time course analysis using K562
cells revealed the same pattern (Fig. 3d), suggesting that E2
can repress the promoter activity of the four MCPH genes.
Interspecific comparison of E2’s repressing effects in different
primate species
To test if the observed E2 regulation of the MCPH genes is
conserved across other primate species, we cloned the pro-
moters of the four MCPH genes from chimpanzees and
macaques (Additional file 3: Figure S3) and tested their re-
sponse to E2 treatments. Similar to the results of the hu-
man genes, promoters from all four MCPH genes in both
chimpanzees and macaques showed repressed activity
Fig. 3 Endogenous MCPH gene expression measurement in human cells treated by E2. a-c Quantitative real-time polymerase chain reaction (PCR)
measure effects of E2 deprivation (white bars) and E2 (black bars) on endogenous ASPM, CDK5RAP2 MCPH1 gene expression in HEK293, MCF7 and
K562 cells, normalized to actin. ASPM, CDK5RAP2, MCPH1 and WDR62 gene expression levels in E2-deprived cells were set as a level of 1-fold expression
level. d ASPM, CDK5RAP2, MCPH1 and WDR62 mRNA were determined by real-time quantitative PCR in K562 cell lines (ASPM: 12 h, p = 0.06, 24 h, p = 0.002;
CDK5RAP2: 12 h, p value is 0.34, 24 h, p = 0.06; MCPH1: 12 h, p = 0.96, 24 h, p = 0.02;). The promoter activity was measured as the ratio of luciferase activity,
which was normalized by setting the value of the control (DMSO treatment) as 1. All histograms represent the mean ± SD of at least three independent
experiments, and each experiment contains three repeats. (*p < 0.05; **p < 0.01; ns : not significant)
Shi et al. BMC Evolutionary Biology  (2015) 15:127 Page 5 of 10under E2 treatments (Additional file 4: Figure S4), with the
exception of a non-significant repression of the macaque
ASPM promoter (Additional file 4: Figure S4E, p = 0.07).
Furthermore, we used a neural cell line (the SK-N-SH cell
line derived from human neuroblastoma) and tested all four
primate species including marmosets. We observed a similar
pattern, in which the repression effects are conserved across
humans, chimpanzees and macaques that are known to ex-
hibit sexual dimorphism (Fig. 4). In marmosets, WDR62
and CDK5RAP2 also showed the repression effects (Fig. 4b
and d), but ASPM and MCPH1 did not (Fig. 4a and c) be-
cause their half ERE sites are not conserved in marmosets
(Fig. 1). This observation is consistent with the fact that
marmosets do not have brain sexual dimorphism [5].
Between-sex gene expression comparison in the human
brain
To trace the dynamic change of expression of the MCPH
genes during brain development, we used currently pub-
lished human brain transcriptome data (www.brainspan.org)
to construct the expression curve of each MCPH gene(Additional file 5: Figure S5). The results showed that there
might be potential expression differences between males
and females for MCPH1 and CDK5RAP2 (Additional file 5:
Figure S5). Further investigation of these genes, particularly
MCPH1 and CDK5RAP2 are warranted.
Discussion
Estrogen is well known to influence numerous sexual di-
morphic traits in both humans and several other pri-
mates, but its role in brain development has never been
clearly articulated. Previous association analysis in
humans indicated that three of the brain size regulating
genes (ASPM, CDK5RAP2 and MCPH1) contain se-
quence variations significantly associated with brain size,
but more provocatively that the associations are sex-
dependent [25, 26], suggesting that sex hormones may
be involved in the regulation of MCPH genes, and by ex-
tension brain size. Among the seven MCPH genes, four
contain half ERE sites in their promoters. Interestingly,
these half ERE sites are generally conserved in those pri-
mates exhibiting sexual dimorphism, suggesting they
Fig. 4 E2 suppresses the promoter activities of MCPH genes in SK-N-SH cells. a-d Quantification of promoter activity of ASPM, CDK5RAP2, MCPH1
and WDR62 using luciferase reporter gene assay. The SK-N-SH cells (derived from human neuroblastoma) were transiently transfected with vector
containing human ERα
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humans. Both the reporter gene assay and endogenous
expression analysis showed that E2 was able to suppress
the expression of these four MCPH genes, implying a
potentially novel role of estradiol in the observed differ-
ences in male and female brain sizes among primates.
The mutant assay indicated that the repressive effect of
E2 was mediated by its direct interaction with the pre-
dicted half ERE sites. Given these results, it is likely that
a majority of the currently known brain size regulating
genes (4/7) in primates is regulated by estradiol, provid-
ing a potential molecular mechanism that explains brain
size dimorphism in humans and nonhuman primates.
The four tested MCPH genes are all expressed in the
neuroepithelium during fetal development and encode
proteins that influence proliferation of neurons in the
ventricular zone of the developing brain [8, 18]. Hence,
it is likely that the sex difference is established early in
development because the size of the neural progenitor
pool determines brain size during fetal brain develop-
ment [36]. A previous report showed that sex-relateddifferences in brain structure are determined mainly by
the hormonal environment present during embryonic
development [37]. Using published RNAseq data of hu-
man fetal brains (http://www.brain-map.org/), we found
a large number of differentially expressed genes (2,433
genes) between males and females. In constrast, there
are only 412 such genes in the adult brains with little
overlap (60 genes) with those in the fetal brains [38]
(Additional file 6: Figure S6), supporting the speculated
early establishment of sex difference in brain develop-
ment. Additionally, puberty time also plays an import-
ant role in postnatal brain development [27, 28]. It was
shown that mean volume of the medial temporal lobe
increases in adolescent boys but decreases in adolescent
girls with the progression of puberty [29].
Also, it was traditionally argued that females reach
puberty earlier than males, therefore, would withdraw
earlier from somatic development. Our findings suggest
that the female hormone estrogen may serve as one of
the key factors causing the between-sex difference of the
brain.
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of MCPH1 is associated with the evolution of sex di-
morphism of anthropoid brain mass [39]. Consistently,
in humans, MCPH1 shows a potential between-sex ex-
pression divergence at two developmental stages (pre-
natal and puberty) (Additional file 5: Figure S5) when
the levels of estradiol are presumably higher in females
than in males. A similar pattern was also seen in
CDK5RAP2 during adulthood (Additional file 5: Figure
S5). However, these potential differences need further
tests. No between-sex difference was detected for the
other two MCPH genes (ASPM and WDR62) (Add-
itional file 5: Figure S5). The difference in effect of estra-
diol suggests that regulation on the MCPH genes by
estradiol is likely dependent on spatial-temporal interac-
tions between estradiol and its targets during brain develop-
ment, though again, more targeted follow-up studies may
prove useful in clarifying this possibility. Given the pro-
posed role of MCPH1 in brain size dimorphism, this may
explain why New World monkeys like the common mar-
moset do not exhibit brain size dimorphism [5] because
two of the three half ERE sites of MCPH1 are not con-
served in the common marmoset (Fig. 1), and no repression
effect by estradiol was detected (Fig. 4c).
To date, molecular evolution studies have found that four
of the seven known MCPH genes—ASPM, CDK5RAP2,
CENPJ and MCPH1—evolved rapidly in primates due to
Darwinian positive selection, which is associated with the
enlargement of the brain during primate evolution and hu-
man origin [23, 24]. For example, the signal of positive se-
lection on MCPH1 was previously inferred in the common
ancestor of great apes and humans as well as in the human
lineage [24]. Surprisingly, the results of our study here
found that three of these fast-evolving MCPH genes over-
lapped with the four MCPH genes under estradiol regula-
tion, suggesting that natural selection may favor parallel
changes of both brain size change and brain size dimorph-
ism. This fits quite well with what we already know, that es-
tradiol is essential for brain development and it can
promote neurite growth and regulate synaptic patterning
[40]. Ultimately then, when natural selection pushes the en-
largement of the brain, it may be that it tends to act on
genes already under estradiol regulation, and our results
suggest that it does so potentially by suppressing the ex-
pression of brain size related genes in females [40].
It should be noted that besides the MCPH genes tested
in this study, there might be other MCPH genes or un-
known regulatory factors contributing to brain sexual di-
morphism in primates. For example, the male sex
hormone (testosterone) may play a role in brain sexual di-
morphism. Also, why natural selection would favor a rela-
tively smaller brain size in females is not clear. One
possible explanation is the differential social roles of males
and females that would lead to differential selectivepressures during evolution. More evidence needs to be col-
lected to test this hypothesis.
Conclusions
We demonstrated that estrogen could down-regulate
four of the known brain size regulating genes. This sup-
pression effect may contribute to between-sex difference
in brain size in humans and nonhuman primates with
brain sexual dimorphism, suggesting that sex hormones
may play an important role in primate brain evolution.
Methods
Cell culture
The HEK293,MCF-7, K562, HL60 and SK-N-SH cell lines
were obtained from ATCC. These cell lines were cultured
in phenol red-free DMEM (Gibco, Rockville, MD) with
10 % fetal bovine serum (Hyclone, Logan, UT) at 37 °C in
a humidified atmosphere containing 5 % CO2. For estro-
gen assays, before treatments, the cells were maintained in
phenol red-free DMEM containing 10 % dextran-coated
charcoal-stripped fetal bovine serum (DCC-FBS) (Hyclone)
for a minimum of 3 days with the media changed every
day. Then the cells were treated with E2 (20nM, dissolved
in DMSO) or DMSO as control for 24 h.
Cloning of the human, chimpanzee and macaque MCPH
gene promoters
The promoters of MCPH1 were cloned in our previous
study [41], or ASPM, MCPH1, CDK5RAP2 and WDR62,
promoters from human, chimpanzee, macaque and marmo-
set were amplified from genomic DNA, and then the >2 kb
amplicons were cloned into the pGL3 basic firefly lucifer-
ase vector (Promega). Primers used for cloning of ASPM,
MCPH1, CDK5RAP2, WDR62 gene 5′-flanking region
are shown in Additional file 7: Table S1. XhoI/HinDIII
and KpnI/NheI restriction sites were respectively intro-
duced in the forward and reverse primer, and employed
for cloning the deletion fragments upstream of the luciferase
reporter gene plasmid. The amplified DNA fragment was
digested with XhoI/HinDIII and KpnI/NheI (Fermentas,
Hanover, MD) and cloned into the pGL3-basic firefly lu-
ciferase reporter vector (Promega, Madison, WI) to con-
struct human-aspm, chimpanzee-aspm, macaque-aspm,
marmoset-aspm, human-cdk5rap2, chimapanzee-cdk5rap2,
macaque-cdk5rap2, macrmoset-cdk5rap2, marmoset-
MCPH1, human-wdr62, chimpanzee-wdr62, macaque-
wdr62, marmoset-wdr62. The sequences of the cloned
DNAs were verified by sequencing the entire region.
MCPH gene promoter sequence alignment
The microcephaly gene promoter sequences of human,
chimpanzee and macaque were obtained from the NCBI
(http://www.ncbi.nlm.nih.gov), EMBL (http://www.ensembl.
org). Orthologous sequences were aligned using Muscle in
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7.0.5.2 (BioEdit).
Mutant human MCPH gene promoter constructs
The cloning of promoter constructs in luciferase reporter
vector, the pGL3 basic vector and the ASPM, CDK5RAP2,
MCPH1 and WDR62 promoter constructs containing
mutations in estrogen receptor binding sites were con-
ducted using QuickChange II XL site-directed mutagen-
esis kit (Stratagene. La Jolla, CA, USA) following the
recommended protocols. The sequences of the mutant
cloned DNAs were verified by sequencing. Primers used
for generating ASPM, CDK5RAP2, MCPH1, WDR62 pro-
moter mutants are listed in Additional file 8: Table S2.
Transient transfection and luciferase reporter assay
To determine whether E2 regulates the microcephaly genes’
promoter activity, all transfections were carried out in trip-
licate in 24-well plates (Corning, NY, USA). About 2 × 105
cells were seeded for 24 h prior to transfection. Equal num-
bers of cells were plated in 24-well and 6-well plates and
grown to 80 % confluence. HEK293T, MCF7 and SK-N-SH
cells were transfected with the indicated amounts of micro-
cephaly promoter constructs, ERα receptor expression plas-
mid (kindly provided by Leigh C. Murphy, University of
Manitoba) including pTK-Renilla as an internal control,
using Lipofectamine 2000 (Invitrogen). After 6 h, the cells
were treated with E2 and DMSO for 24 h.
Luciferase activity was assayed 24 h after transfection.
The luciferase activity in cell extracts was determined by
Dual-luciferase Reporter Assay System (Promega, Madison,
WI) according to the manufacturer’s protocols. The rela-
tive light units were measured using a luminometer. Each
experiment was repeated at least three times to ensure ac-
curacy. The promoter activity was measured as the ratio of
luciferase activity, which was normalized by setting the
value of the control (DMSO treatment) as 1. All histo-
grams represent the mean ± SD of at least three independ-
ent experiments, and each experiment contains six repeats
(*p < 0.05; **p < 0.01; ns : not significant).
RT-PCR
Total RNA was extracted using TRIzol (Invitrogen,
Carlsbad,CA). The RNA was treated with DNase I
(Fermentas) to remove possible genomic DNA contamin-
ation, then subjected to reverse transcription using an
oligo-dT(20) primer and Ominicript Reverse transcriptase
(Qiagen, Valencia, CA).
MCF-7 real time quantitative PCR
To determine the effect of estrogen on the endogenous
MCPH gene expression, MCF-7 cells were treated with
E2 (20nM) and control DMSO (same amount volume)
for 24 h. These RNAs were reverse transcribed with anoligo-dT(20) primer and amplified with real-time PCR
primers. Real time PCR reactions (15-ul total volume con-
taining 0.5-ul 10um primer,7.5-ul SYBR Green Dye (Bio-Rad,
CA, USA), and 2-ul of cDNAs) were carried out with a
DNA Engine Opticon Continuous Fluorescence Detection
System(MJ Research, Waltham MA) for ~40 cycles. Ct
values for each gene amplification were normalized by
subtracting the Ct value calculated for actin. The normal-
ized gene expression values were expressed as the relative
quantity of ASPM, CDK5RAP2, MCPH1, WDR62 gene-
specific messenger RNA (mRNA). The oligonucleotide
primers used in the real-time quantitative PCR amplifica-
tions are shown in Additional file 9: Table S3.
K562 time series real time quantitative PCR
K562 cells were treated with E2(20nM) and control
DMSO(the same amount volume) for 0, 24, 48 h. These
RNAs were reverse transcribed with oligo-dT(20) primer
and amplified by real-time PCR primers. Real-time PCR
reactions (15-ul total volume containing 0.5-ul 10um pri-
mer,7.5d-ul SYBR Green Dye from Bio-Rad (CA, USA),
and 2-ul of cDNAs) were carried out with a DNA Engine
Opticon Continuous Fluorescence Detection System (MJ
Research, Waltham. MA) for ~40 cycles. Ct values for
each gene amplification were normalized by subtracting
the Ct value calculated for GAPDH. The normalized gene
expression values were expressed as the relative quantity
of ASPM, CDK5RAP2, MCPH1, WDR62 gene-specific
messenger RNA (mRNA).
Human brain development expression data analysis
We downloaded human brain development expression
RNAseq data of ASPM, CDK5RAP2, MCPH1 and
WDR62 gene from the Atlas of the Developing Human
Brain (www.brainspan.org) covering the developing
stages ranging from 5–7 post-conceptional weeks (pcw)
to over 40 years of age (Additional file 10: Table S4).
The RPKM (reads per kilobase per million) value was
used to indicate the expression level of ASPM,
CDK5RAP2, MCPH1 and WDR62 gene. We divided the
brain developmental stages into prenatal time and post-
natal. However, due to the sampling strategy of the data-
base, the data is not exactly point to point between
males and females.
Prenatal brain gene expression analysis
We downloaded RNAseq data of human fetal brains
from the Atlas of the Developing Human Brain
(www.brainspan.org) covering 8–26 post-conception
weeks (pcw). Differentially expressed genes between males
and females were determined with the DEseq package
[42], by modeling count data using a negative binomial
distribution. First, size factors are calculated by taking into
account the total number of reads in different samples.
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gene accounting for biological variation between samples.
Finally, a negative binomial distribution is used to fit the
counts for each gene. The p-value is calculated based on
the fold changes. The p values adjusted for multiple test-
ing was calculated using the Benjamini-Hochberg proced-
ure, which controls false discovery rate (FDR).
Statistical analysis
Statistical analyses were performed using Prism 5
(GraphPad); Data was analyzed using the two-tailed Stu-
dent’s t test. P-values <0.05 were considered as statistically
significant. ANOVA analysis was performed using the R
program (http://www.r-project.org/).
Additional filesAdditional file 1: Figure S1. Different dosages of E2 (1nM-50nM)
repress the promoter activity of MCPH1. The promoter activity was
measured as the ratio of luciferase activity by setting the value of the
internal control (empty vector) as one. All histograms represent the
mean ± SD of at least three independent experiments, and each
experiment includes six repeats. (*p < 0.05; **p < 0.01; ns : not significant).
Additional file 2: Figure S2. The repression effect of E2 (5nM) on the
promoter activities of the four MCPH genes. HEK293T cells were transiently
transfected with empty vector and vector containing human ERα. Cells were
treated with 5nM E2 or the same volume DMSO for 36 hours prior to assaying
reporter activity using dual-luciferase assays. All histograms represent the
mean ± SD of at least three independent experiments, and each experiment
include six repeats. (*p < 0.05; **p < 0.01; ns : not significant).
Additional file 3: Figure S3. Promoter activity tests of the MCPH genes
of chimpanzee and rhesus macaque using reporter gene assays. The
promoter activity was measured as the ratio of luciferase activity, which
was normalized by setting the value of the internal control (empty
vector) as one.
Additional file 4: Figure S4. E2 represses the promoter activities of
chimpanzee and macaque MCPH genes. (A-D) Quantification of repressive
activity of chimpanzee ASPM, CDK5RAP2, MCPH1 and WDR62 promoter
using luciferase reporter gene assay. (E-H) Quantification of repressive
activity of macaque ASPM, CDK5RAP2, MCPH1 and WDR62 promoter using
luciferase reporter gene assay. HEK293T cells were transiently transfected
with vector containing human ERα. Cells were treated with 20nM E2 or
the same volume DMSO for 36 h prior to assaying reporter activity using
dual-luciferase assays. All histograms represent the mean ± SD of at least
three independent experiments, and each experiment contains six repeats.
(*p < 0.05; **p < 0.01; ns : not significant).
Additional file 5: Figure S5. Expression changes of the MCPH genes
during human brain development. (A-D) Curve of ASPM, CDK5RAP2,
MCPH1 and WDR62 expression changes in PFC during human brain
development. The shaded areas indicate the developmental stages
showing up-regulation of CDK5RAP2 and MCPH1 in males compared
with females.
Additional file 6: Figure S6. Comparison of the between-sex differentially
expressed genes in the prenatal and postnatal (adult) human brains.
Additional file 7: Table S1. Primers used for cloning the 5′-flanking
region of the microcephaly genes.
Additional file 8: Table S2. Primers used for generating estrogen
receptor binding site mutants of the MCPH gene promoter constructs.
Additional file 9: Table S3. Primers used for real-time quantitative PCR.
Additional file 10: Table S4. The brain samples of different developmental
stages used in this study from published data at www.brainspan.org.Competing interests
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